[go: up one dir, main page]

WO1998032469A3 - Polymers - Google Patents

Polymers Download PDF

Info

Publication number
WO1998032469A3
WO1998032469A3 PCT/GB1998/000270 GB9800270W WO9832469A3 WO 1998032469 A3 WO1998032469 A3 WO 1998032469A3 GB 9800270 W GB9800270 W GB 9800270W WO 9832469 A3 WO9832469 A3 WO 9832469A3
Authority
WO
WIPO (PCT)
Prior art keywords
linked
polymer backbone
compounds
polymers
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1998/000270
Other languages
French (fr)
Other versions
WO1998032469A2 (en
Inventor
Henry Wolfe
Kenneth Kellar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9701813.9A external-priority patent/GB9701813D0/en
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Priority to CA002278200A priority Critical patent/CA2278200A1/en
Priority to AU58717/98A priority patent/AU5871798A/en
Priority to JP53176198A priority patent/JP2001509796A/en
Priority to EP98902085A priority patent/EP1011736A2/en
Publication of WO1998032469A2 publication Critical patent/WO1998032469A2/en
Publication of WO1998032469A3 publication Critical patent/WO1998032469A3/en
Priority to NO993662A priority patent/NO993662L/en
Anticipated expiration legal-status Critical
Priority to US10/057,943 priority patent/US20020076378A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Polyethers (AREA)

Abstract

The invention provides compounds comprising a linear, branched or dendrimeric polymer backbone with linked thereto at least one reporter moiety, said polymer backbone comprising a plurality of amine-containing acids. Such compounds may be linked to one or more targeting agents and are useful as therapeutic and diagnostic agents, in particular in medical imaging techniques.
PCT/GB1998/000270 1997-01-29 1998-01-29 Polymers Ceased WO1998032469A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002278200A CA2278200A1 (en) 1997-01-29 1998-01-29 Polymers
AU58717/98A AU5871798A (en) 1997-01-29 1998-01-29 Polymers
JP53176198A JP2001509796A (en) 1997-01-29 1998-01-29 Polymer
EP98902085A EP1011736A2 (en) 1997-01-29 1998-01-29 Polymers
NO993662A NO993662L (en) 1997-01-29 1999-07-28 polymers
US10/057,943 US20020076378A1 (en) 1997-01-29 2002-01-29 Polymers

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9701813.9A GB9701813D0 (en) 1997-01-29 1997-01-29 Polymers
GB9701813.9 1997-01-29
US5707497P 1997-08-27 1997-08-27
US60/057,074 1997-08-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US36271199A Continuation 1997-01-29 1999-07-29

Publications (2)

Publication Number Publication Date
WO1998032469A2 WO1998032469A2 (en) 1998-07-30
WO1998032469A3 true WO1998032469A3 (en) 1998-11-05

Family

ID=26310882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/000270 Ceased WO1998032469A2 (en) 1997-01-29 1998-01-29 Polymers

Country Status (8)

Country Link
EP (1) EP1011736A2 (en)
JP (1) JP2001509796A (en)
KR (1) KR20000070544A (en)
CN (1) CN1246059A (en)
AU (1) AU5871798A (en)
CA (1) CA2278200A1 (en)
NO (1) NO993662L (en)
WO (1) WO1998032469A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6078399A (en) * 1998-09-29 2000-04-17 Arne Holm Ligand presenting assembly (lpa), method of preparation and uses thereof
AU5522600A (en) * 1999-06-29 2001-01-22 Dako A/S Detection using dendrimers bearing labels and probes
ITFO990015A1 (en) * 1999-07-23 2001-01-23 Verdini Antonio "POLYPEPTIDE DENDRIMERS AS UNIMOLECULAR CARRIERS OF DRUGS AND BIOLOGICALLY ACTIVE SUBSTANCES".
KR100379720B1 (en) * 2000-10-14 2003-04-11 주식회사 마크로젠 Supporter containing drimer monolayer and manufacturing method of same
ATE494913T1 (en) * 2004-11-22 2011-01-15 Ge Healthcare As CONTRAST AGENTS FOR AN EXTRACELLULAR MATRIX
JP4870941B2 (en) * 2005-05-09 2012-02-08 公立大学法人大阪府立大学 High molecular compound
KR101334780B1 (en) * 2010-08-13 2013-12-02 한국생명공학연구원 Iodine-containing radial-shape macromolecular compounds, preparation method thereof and contrast medium compositions for CT comprising the same
EP3906414A1 (en) * 2019-01-03 2021-11-10 Ionpath, Inc. Compositions and reagents for ion beam imaging
CN113307863B (en) * 2021-05-25 2022-12-16 华南农业大学 Preparation method and application of polyaspartic acid and salt antibody thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002611A1 (en) * 1983-12-12 1985-06-20 Scripps Clinic And Research Foundation Synthetic polypeptide corresponding to a portion of the heat-labile enterotoxin of escherichia coli, compositions and methods therewith
EP0331616A2 (en) * 1988-02-29 1989-09-06 Schering Aktiengesellschaft Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same
EP0481526A1 (en) * 1989-04-07 1992-04-22 Nycomed Salutar, Inc. Chelants
WO1993006868A1 (en) * 1991-10-07 1993-04-15 COCKBAIN, Jilian, Roderick, Michaelson Dendrimeric polychelants
WO1993010824A1 (en) * 1991-12-04 1993-06-10 Guerbet S.A. Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
WO1994005203A1 (en) * 1992-09-04 1994-03-17 The General Hospital Corporation Biocompatible polymers containing diagnostic or therapeutic moieties
WO1996040816A1 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Iodine-containing linear polyamines and polyamides
WO1996040760A2 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Iodine-containing peptides and their use as x-ray contrast media

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002611A1 (en) * 1983-12-12 1985-06-20 Scripps Clinic And Research Foundation Synthetic polypeptide corresponding to a portion of the heat-labile enterotoxin of escherichia coli, compositions and methods therewith
EP0331616A2 (en) * 1988-02-29 1989-09-06 Schering Aktiengesellschaft Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same
EP0481526A1 (en) * 1989-04-07 1992-04-22 Nycomed Salutar, Inc. Chelants
WO1993006868A1 (en) * 1991-10-07 1993-04-15 COCKBAIN, Jilian, Roderick, Michaelson Dendrimeric polychelants
WO1993010824A1 (en) * 1991-12-04 1993-06-10 Guerbet S.A. Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
WO1994005203A1 (en) * 1992-09-04 1994-03-17 The General Hospital Corporation Biocompatible polymers containing diagnostic or therapeutic moieties
WO1996040816A1 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Iodine-containing linear polyamines and polyamides
WO1996040760A2 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Iodine-containing peptides and their use as x-ray contrast media

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RANGANATHAN, DARSHAN ET AL: "Synthesis of totally chiral, multiple armed, poly Glu and poly Asp scaffoldings on bifunctional adamantane core", TETRAHEDRON LETT., 1997, 38, 1265-1268, XP004034251 *

Also Published As

Publication number Publication date
NO993662D0 (en) 1999-07-28
CN1246059A (en) 2000-03-01
AU5871798A (en) 1998-08-18
CA2278200A1 (en) 1998-07-30
KR20000070544A (en) 2000-11-25
EP1011736A2 (en) 2000-06-28
WO1998032469A2 (en) 1998-07-30
JP2001509796A (en) 2001-07-24
NO993662L (en) 1999-09-28

Similar Documents

Publication Publication Date Title
CA2283939A1 (en) Non-antigenic branched polymer conjugates
EP2277549A3 (en) Therapeutic polyanhydride compounds for drug delivery
FI964217L (en) Easily degradable star-block polymers
WO1999029353A3 (en) Medical devices with improved properties
CA2186858A1 (en) Surface-modifying endgroups for biomedical polymers
BRPI9809791B8 (en) aminoalkyl glucosamine phosphate immuno-effecting compounds and compositions comprising the same
ID28833A (en) 3-ARIL-2-HYDROXYOPROPIONATIC ACID DEGREE
TR199800848A3 (en) Compounds with elevated in vivo compatibility.
EP3449946A3 (en) Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
CA2111925A1 (en) Thermoplastic polyurethanes modified by siloxane block copolymers
DZ3165A1 (en) Food or pharmaceutical composition used to prevent or treat hyperoxaluria.
DK0788515T3 (en) Non-antigenic branched polymer conjugates
IL83567A (en) Starburst conjugates with a carried material,such as an agricultural or pharmaceutical material
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
WO1998032469A3 (en) Polymers
EP0922448A3 (en) A humectant and an endermic liniment
DE69611681D1 (en) TOUGH THERMOPLASTIC POLYMER COMPOSITIONS
ID18712A (en) 4-BIFENYL-4-HYDROXYBUTIRATE ACIDED SUBSTANCES AS METALOPROTEASE MATRIERS
TR199902775T2 (en) (S) -Camptothecin glycoconjugeleri.
AU4972397A (en) I.v. catheter with needle guard
AU3698297A (en) Compositions containing at least one nucleic acid and their applications in the biomedical field, particularly in gene therapy
FR2716375B3 (en) Medical injector.
WO1998030717A3 (en) Vegetal sequences including a polymorphic site and their uses
WO2000027860A3 (en) Polynucleotide crosslinking agents
FI970696A7 (en) Oligonucleotide conjugates, compositions and methods for degrading ribonucleic acids

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98802158.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998902085

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2278200

Country of ref document: CA

Ref document number: 2278200

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/006836

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 1998 531761

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1019997006789

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 09362711

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998902085

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997006789

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1019997006789

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1998902085

Country of ref document: EP